Medesis Pharma is developing a radioprotection drug to treat people irradiated following
NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse
Systemic Delivery of siRNA Down Regulates Brain Prion Protein and Ameliorates Neuropathology
Phase behavior of reverse microemulsions based on Peceol® Mouri A, Diat O,
Water solubilization capacity of pharmaceutical microemulsions based on Peceol®,
Development of pharmaceutical clear gel based on Peceol®, lecithin, ethanol and
Formulation, physicochemical characterization and stability study of lithium-loaded
In situ synthesis of Prussian blue nanoparticles within a biocompatible reverse micellar
Systemic delivery of P42 peptide: a new weapon to fight Huntington’s disease
BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early
